Zentalis Pharmaceuticals, Inc.·4

Jul 20, 8:28 PM ET

Bunker Kevin D. 4

4 · Zentalis Pharmaceuticals, Inc. · Filed Jul 20, 2022

Insider Transaction Report

Form 4
Period: 2022-07-20
Bunker Kevin D.
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2022-07-20$30.00/sh5,000$150,000100,000 total(indirect: See Footnote)
Holdings
  • Common Stock

    764,110
  • Common Stock

    (indirect: As UTMA custodian for sons)
    350
Footnotes (2)
  • [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021.
  • [F2]Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.

Documents

1 file
  • 4
    wf-form4_165836329544214.xmlPrimary

    FORM 4